Alan List - Mar 3, 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Signature
/s/ Dario Scimeca, Attorney-in-Fact for Alan List
Stock symbol
DTIL
Transactions as of
Mar 3, 2023
Transactions value $
-$10,136
Form type
4
Date filed
3/7/2023, 04:16 PM
Previous filing
Jan 24, 2023
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +29.5K +161.3% 47.7K Mar 3, 2023 Direct F1, F2
transaction DTIL Common Stock Sale -$10.1K -9.47K -19.85% $1.07 38.2K Mar 6, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 +29.5K +100.05% $0.00 58.9K Mar 3, 2023 Common Stock 29.5K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.